Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin Peglispro vs Insulin Glargine in T2DM (IMAGINE 4)
NCT01468987Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Dec 2011
- Primary completion
- Aug 2013
- Modality
- Polymer-based Nanoparticles, Recombinant Proteins and Enzymes
- Countries
- 25
01
Overview
A Phase 3 trial of insulin peglispro in type 2 diabetes mellitus (T2DM), sponsored by Eli Lilly and Company. Started Dec 2011; status: completed.
02
Drugs
insulin peglispro
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01468987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01468987.